Production of Recombinant Salmon Calcitonin by In Vitro Amidation of an Escherichia coli Produced Precursor Peptide

Salmon calcitonin (sCT) is a 32 amino acid peptide hormone that requires C-terminal amidation for full biological activity. We have produced salmon calcitonin by in vitro amidation of an E. coli produced precursor peptide. Glycine-extended sCT, the substrate for amidation, was produced in recombinant E. coli as part of a fusion with glutathione-S-transferase. The microbially produced soluble fusion protein was purified to near homogeneity by affinity chromatography. Following S-sulfonation of the fusion protein, the glycine-extended peptide was cleaved from the fusion by cyanogen bromide. The S-sulfonated peptide was recovered and enzymatically converted to the amidated peptide in a reaction with recombinant peptidylglycine -amidating enzyme (-AE) secreted from Chinese hamster ovary (CHO) cells. After reformation of the intramolecular disulfide bond, the sCT was purified with a step yield of 60%. The ease and speed of this recombinant process, as well as its potential for scale-up, make it adaptable to production demands for calcitonin, a proven useful agent for the treatment of post-menopausal osteoporosis. Moreover, the relaxed specificity of the recombinant -AE for the penultimate amino acid which is amidated allows the basic process to be applied to the production of other amidated peptides.

1. Wallis, M., Howell, S.L. and Taylor, K.W. 1985. Parathyroid hormone andcalcitonin, Chapter 13. In: The Biochemistry of the Polypeptide Hormones. John Wiley and Sons, N.Y.
2. Wolfe, H.J. 1982. Calcitonin: Perspectives in current concepts. J. Endo. Inv. 5: 423−432. | ISI | ChemPort |
3. Welch, S.P., Cooper, C.W. and Dewey, W.L. 1986. Antinociceptive activity ofsalmon calcitonin injected intraventricularly in mice: Modulation of morphineantinociception. J. Pharm. Exp. Ther. 237(1) 54−58. | ISI | ChemPort |
4. Agrawal, R., Wallach, S., Cohn, S., Tessier, M., Verch, R., Hussain, M. and Zanzi, I. 1981. Calcitonin treatment of osteoporosis, p. 227−246. In: Calcitonin 1980. A. Pecile (Ed.). Excerpta Medica, Amsterdam.
5. Haas, H.G., Liebrich, B.M. and Schaffner, W. 1990. Calcitonin and osteoporosis—A critical review of the literature 1980−1989. Klin Wochenschr. 68: 359−371. | PubMed  | ISI | ChemPort |
6. McDermott, M. and Kidd, G.S. 1982. The role of calcitonin in the developmentand treatment of osteoporosis. Endocrine Reviews 8 (4): 377−390.
7. Overgaard, K., Riis, B.J., Christiansen, C., Podenphant, J. and Johansen, J.S.1989. Nasal calcitonin for treatment of established osteoporosis. Clin. Endo. 30: 435−442. | ISI | ChemPort |
8. Overgaard, K., Agnusdei, D., Hansen, M.A., Maioli, E., Christiansen, C. and Gennari, C. 1991. Dose response bioactivity and bioavailability of salmoncalcitonin in premenopausal and postmenopausal women. J. Clin. Endo. Met. 72(2): 344−349. | ISI | ChemPort |
9. Reginster, J.Y., Deroisy, R., Lecart, M.P., Sarlet, N., Fontaine, M.A., Albert, A. and Franchimont, P. 1990. Calcitonin and postmenopausal bone loss. Exp. Geront. 25(3,4): 349−356. | Article | ISI | ChemPort |
10. Reginster, J.Y., Gennari, C., Mautalen, C., Deroisy Denis, D., Lecart, M.P., Vandalem, J.L., Collette, J. and Franchimont, P.1990b. Influence of specificanti-salmon calcitonin antibodies on biological effectiveness of nasal salmoncalcitonin in Paget's disease of the bone. Scand. J. Rheum. 19 83−86. | ISI | ChemPort |
11. Rittinghaus, E.F., Hesch, R.D., Harms, H.M., Busch, U., Prokop, M. and Delling, G. 1990. The concept and treatment of osteoporosis. Exp. Geront. 25(3,4): 357−365. | Article | ISI | ChemPort |
12. Vega, E., Gonzalez, D., Ghiringhelli, G. and Mautalen, C. 1989. Acute effect ofthe intranasal administration of salmon calcitonin in osteoporotic women. Bone and Mineral. 9: 267−273. | Article |
13. Norman, A. and Litwack, G. 1987. Calcium regulating hormones, p. 355−396. In: Hormones. Academic Press, N.Y.
14. Epand, D.M., Epand, R.F., Stafford, A.R. and Orlowski, R.C. 1988. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule. J. Med. Chem. 31: 1595−1598. | PubMed  | ISI |
15. Orlowski, R.C., Epand, R. and Stafford, A.R. 1987. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridgering structure. Eur. J. Biochem. 162: 399−402. | PubMed  | ISI | ChemPort |
16. Smith, D.B. and Johnson, K.S. 1988. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene. 67: 31−40. | Article | PubMed  | ISI | ChemPort |
17. Lundblad, R.L. 1984. Chemical cleavage of peptide Bonds, p. 49−57. In: Chemical Reagents for Protein Modification, Vol I. CRC Press, Boca Raton, FL.
18. Gilligan, J.P., Warren, T.G., Koehn, J.A., Young, S.D., Bertelsen, A.H. and Jones, B.N. 1987. Purification of a fusion protein containing recombinant humancalcitonin. BioChromatography 2(1): 20−27. | ChemPort |
19. Tamburini, P.P., Jones, B.N., Consalvo, A.P., Young, S.D., Lovato, S.J., Gilligan, J.P., Wennogle, L.P., Erion, M. and Yeng, A.Y. 1988. Structure-activityrelationships for glycine-extended peptides and the -amidating enzyme derived from medullary thyroid CA-77 cells. Arch. Biochem. Biophys. 267(2): 623−631. | PubMed  | ISI | ChemPort |
20. Tamburini, P.P., Young, S.D., Jones, B.N., Palmesino, R.A. and Consalvo, A.P. 1990. Peptide substrate specificity of the -amidating enzyme isolated from ratmedullary thyroid CA-77 cells. Int. J. Peptide and Protein Res. 35: 153−156. | ISI | ChemPort |
21. Bradbury, A.F., Finnic, M.D.A. and Smyth, D.G. 1982. Mechanism of C-terminal amide formation by pituitary enzymes. Nature 298: 686−688. | PubMed  | ISI | ChemPort |
22. Gearing, D.P., Nicola, N.A., Metcalf, D., Foote, S., Wilson, T.A., Gough, N.M. and Williams, R.L. 1989. Production leukemia inhibitory factor inEscherichia coli by a novel procedure and its use in maintaining embryonic stem cells in culture. Bio/Technology 7: 1157−1161. | ISI | ChemPort |
23. Chan, W.W.C. 1968. A method for complete S-sulfonation of cysteine residues inproteins. Biochemistry 8 (12): 4247−4254.
24. Han, K.K., Richard, C. and Biserte, G. 1983. Current developments in chemical cleavage of proteins, minireview. Int. J. Biochem. 15 (7): 875−884. | Article | ISI | ChemPort |
25. Miller, D.A., Sayad, K.U., Kulathila, R., Beaudry, G.A., Merkler, D.J., Merkler, D.J. and Bertelsen, A.H. 1992. Production and characterization of recombinant bifunctional peptidylglycine -amidating enzyme expressed in Chinese hamster ovary Cells. Arch. Biochem. Biophys. 298: 380−388. | PubMed  | ISI | ChemPort |
26. Urlaub, G., Mitchell, P.J., Kas, E., Chasin, L.A., Funanage, V.L., Myoda, T.T. and Hamlin, J. 1986. Effect of gamma rays at the dihydrolate reductase locus: Deletions and inversions. Somat. Cell. Mol. Genet. 12 (6): 555−566. | PubMed  | ISI | ChemPort |
27. Sturmer, A., Driscoll, D.P. and Jackson-Matthews, D.E. 1991 A quantitative immunoassay using chicken antibodies for detection of native or recombinant -amidating enzyme. J. Imm. Methods. 146 (1): 105−110. | Article | ISI |
28. Gilligan, J.P., Lovato, S.J., Mehta, N.M., Bertelsen, A.H., Jeng, A. and Tamburini, P.P. 1989. Multiple forms of peptidyl -amidating enzyme: Purification from rat medullary thyroid carcinoma CA-77 Cell-conditioned medium. Endocrinology 124 (6): 2729−2736. | PubMed  | ISI | ChemPort |
29. Merkler, D.J., Kulathila, R.K., Tamburini, P.P. and Young, S.D. 1992. Selective inactivation of the hydrolase activity of bifunctional rat peptidylglycine -amidating enzyme. Arch. Biochem. Biophys. 294 (2): 594−602. | PubMed  | ISI | ChemPort |
30. Kumar, M.A., Slack, E., Edwards, A., Soliman, H.A., Baghdianz, A., Foster, G.V. and Maclntyre, I. 1965. A biological assay for calcitonin. J. Endocrin. 33: 469−475. | ISI | ChemPort |
31. Raisz, L.G., Simmons, H.A., Thompson, W.J., Shepard, K.L., Anderson, P.S. and Rodan, G.A. 1988. Effects of a potent carbonic anhydrase inhibitor on boneresorption in organ culture. Endocrinology 122 (3): 1083−1086. | PubMed  | ISI | ChemPort |
32. Rittel, W., Maier, R., Brugger, B., Kamber, B., Rimker, B. and Sieber, P. 1976. Structure activity relationship of calcitonin. III. Biological activity of synthetic analogues with shortened or terminally modified peptide chains. Experimentia 32: 246−248. | ChemPort |
33. Pratt, G.E., Farnsworth, D.E., Siegel, N.R., Fok, K.F.and Feyereiser, R.1989. Identification of an allostatin from adult Diploptem punctata. Biochem. Biophys. Res. 163: 1243−1247. | ISI | ChemPort |
34. Eipper, B.A. and Mains, R.E. 1988. Peptide -amidation. In: Ann. Rev. of Physiology 50: 333−344. | Article | ISI | ChemPort |
35. Mains, R.E., Eipper, B.A., Glembotski, C.C. and Dores, R.M. 1983. Strategies for the biosynthesis of bioactive peptides. Trends in Neuroscience. 6: 229−235. | Article | ISI | ChemPort |
36. Eipper, B.A., Stoffers, D.A. and Mains, R.E. 1992. The biosynthesis of neuro-peptides: Peptide a-amidation. In: Ann. Rev. of Neuroscience 15: 57−85. | Article | ISI | ChemPort |
37. Bertelsen, A.H., Beaudry, G.A., Galella, E.A., Jones, B.N., Ray, M.L.and Mehta, N.M. 1990. Cloning and characterization of two alternatively spliced rata-amidating enzyme cDNAs from medullary thyroid carcinoma. Arch. Biochem. Biophys. 279: 87−96. | PubMed  | ISI | ChemPort |
38. Beaudry, G.A., Mehta, N.M., Ray, M.L. and Bertelsen, A.H. 1990. Purification and characterization of functional recombinant -amidating enzymesecreted from mammalian Cells. J. Biol. Chem. 265: 17694−17699. | PubMed  | ISI | ChemPort |
39. Bongers, J., Felix, A.M., Campbell, R.M., Lee, Y., Merkler, D.J. and Heimer, E.P. 1992. Semisynthesis of human growth hormone-releasing factors by -amidating enzyme catalyzed oxidation of glycine-extended recursors. Peptide Res. 5 (4): 1−7.
40. Gilligan, J.P., Lovato, S.J., Young, S.D., Jones, B.N., Koehn, J.A., LeSueur, L.F., Sturmer, A.M., Bertelsen, A.H., Warren, T.G., Birnbaum, R.S. and Roos, B.A. 1986. Characterization of an -amidating enzyme from rat CA-77 Cells: Its use for the production of recombinant human calcitonin -met GHRF, p. 38−39. In: Advances in Gene Technology: Molecular Biology of the Endocrine System. D. Duett, F. Ahmad, S. Black, et al. (Eds. ). ICSU Press, Cambridge, UK.
41. Engels, J.W., Glauder, J., Mullner, H., Tripier, D., Uhlmann, E. and Wetekam, W. 1987. Enzymatic amidation of recombinant (Leu²⁷) growth hormone releasing hormone-gly⁴⁵. Protein Eng. 1 (3): 195−199. | PubMed  | ISI | ChemPort |
42. Engels, J.W., Glauder, J., Mullner, H., Uhlmann, E., Wetekam, W., Gotoh, T.H. and Scheikl-Lenz, B. 1987. Chemoenzymatic gene synthesis of a gene forhuman growth hormone releasing hormone (hGHRH), Its expression in E. coli and enzymatic amidation. 1987. Nucleosides and Nucleotides 6: 185−195. | ChemPort |
43. Jones, B.N. 1990. Production of human calcitonin by recombinant DNAtechnology, p. 171−179. In: Fundamentals of Protein Biotechnology. S. Stein (Ed. ). Marcel Dekker, Inc., NY. | ChemPort |
44. Tajima Masahiro Iida, I., Kaminuma, T., Yanagi, M. and Fukushima, S. 1991. High level synthesis in Escherichia coli of recombinant human calcitonin: Collagenase cleavage of the fusion protein and peptidylglycine -amidation. J. Perm, and Bioeng. 72 (5): 362−367.
45. Ray, V.L., VanDuyne, P., Shields, P.P., Charles, D., Merkler, D.J., Consalvo, A.P., Gilligan, J.P., Bertelsen, A.H. and Young, S.D. 1991. Production of recombinant calcitonin gene-related peptide by in vitro amidation of an E. coli produced peptide. Regulatory Peptides 34 (2): 93. | Article |
46. Mehta, N.M., Gilligan, J.P., Jones, B.N., Bertelsen, A.H., Roos, B.A. and Birnbaum, R.S. 1988. Purification of a peptidyl glycine -amidating enzyme from transplantable rat medullary thyroid carcinomas. Arch. Biochem. Biophys. 261: 44−54. | PubMed  | ISI | ChemPort |
47. Guttman, S. 1981. Chemistry and structure-activity relationship of natural andsynthetic calcitonins. In: Calcitonin 1980. A. Pecile (Ed. ). Excerpta Medica,Amsterdam.
48. Maniatis, T., Fritsch, E.F. and Sambrook, J. 1982. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N. Y.
49. Kraft, R., Tardiff, J., Krauter, K.S. and Leinwand, L.A. 1988. Using mini-prep plasmid DNA for sequencing double-stranded templates with Sequenase^TM. Biotechnique 6 (5): 544−549. | ISI | ChemPort |
50. Weaver, K., Chen, D., Walton, L., Elwell, L. and Ray, P. 1990. Uridinephosphorylase purified from total crude extracts of Eschericia coli. BioPharm. July-August: 25−28.
51. Simons, P.C. and VanderJagt, D.L. 1977. Purification of glutathione-S-frans-ferases from human liver by glutathione affinity chromatography. Anal. Bio chem. 82: 334−341. | ChemPort |
52. Wetzel, R., Kleid, D.G., Crea, R., Heyneker, H.L., Yansura, D.G., Hirose, T.A., Riggs, A.D., Itakura, K. and Goeddel, D.V. 1981. Expression in Escherichia coli of a chemically synthesized gene for a "mini-C" analog of human proinsulin. Gene 16: 63−71. | PubMed  | ChemPort |
53. Jones, B.N., Tamburini, P.T., Consalvo, A.P., Young, S.D., Lovato, S.J., Gilligan, J.P., Jeng, A.Y. and Wennogle, L.P. 1988. A fluorometric assay for peptidyl -amidation activity using high performance liquid chromatography. Anal. Biochem. 68: 272.

	Top

	Top